Topics covered: Value-driven, Undervalued Assets With Potential, Top-down Approach, MLP Investing Strategies, Long-only Strategy
Companies covered: ProLogis, Inc. (NYSE:PLD), Multi-Fineline Electronix, Inc. (NASDAQ:MFLX), Citigroup Inc. (NYSE:C), AXA, Watson Pharmaceuticals Inc., Teva Pharmaceutical Industries Limited (NYSE:TEVA), Johnson & Johnson (NYSE:JNJ), Human Genome Sciences Inc., NutriSystem Inc (NASDAQ:NTRI), Cubist Pharmaceuticals Inc., BP p.l.c. (NYSE:BP), Baxter International Inc. (NYSE:BAX), Bank of America Corporation (NYSE:BAC), American International Group, Inc. (NYSE:AIG), Abbott Laboratories (NYSE:ABT), Wilmington Trust Corporation, Stryker Corporation (NYSE:SYK), Quintiles Transitional Holdings Inc. (NYSE:Q), Pepsico, Inc. (NASDAQ:PEP), Medtronic, Inc. (NYSE:MDT), Coca-Cola Company (The) (NYSE:KO), Interpublic Group of Companies, Inc. (The) (NYSE:IPG), Becton, Dickinson and Company (NYSE:BDX), C.R. Bard, Inc. (NYSE:BCR)
